#USA #Overland Park #Dendi #Molecular Lab Partners #lab solutions

Dendi and Molecular Lab Partners Form Strategic Alliance

Dendi, recognized as a leading provider of cloud-native laboratory information systems (LIS), has recently forged a strategic partnership with Molecular Lab Partners (MLP). This collaboration aims to enhance laboratory capabilities nationwide, particularly in the implementation of physician office laboratories (POLs), urgent care centers, and multi-location lab networks.

This alliance combines Dendi's advanced LIS platform with MLP's comprehensive consulting services, which specialize in rapid and efficient high-complexity laboratory implementations. The goal is to streamline the establishment of in-house polymerase chain reaction (PCR) testing capabilities. This will enable healthcare organizations to conduct a variety of tests—including those for COVID-19, respiratory illnesses, sexually transmitted infections (STIs), and urinary tract infections (UTIs)—without the need to rely on external reference laboratories.

By integrating their strengths, Dendi and MLP intend to facilitate a faster transition for laboratory operations into the clinical setting. The partnership covers everything from ensuring regulatory compliance and assay validation to providing software integration and operational support for live testing environments. This holistic approach is designed to help laboratories become operational more swiftly, ultimately maximizing the value captured from reimbursement processes.

Jihoon Baek, the CEO of Dendi, expresses his enthusiasm for this partnership, stating, "We're thrilled to partner with Molecular Lab Partners to bring rapid, scalable solutions to POLs and urgent care labs nationwide. Together, we're helping to advance diagnostics by making operations easier for all different types of labs. With Dendi's LIS platform and MLP's hands-on expertise, clients can stand up multi-site operations with confidence—fast, compliant, and integrated quickly."

Reflecting on this monumental step, Joe Renzi, Co-Founder of MLP, comments on the potential this partnership holds. "This collaboration marks an exciting milestone for Molecular Lab Partners. By combining our expertise in high complexity laboratory implementation with Dendi's innovative cloud-based LIS for CLIA labs—those performing both routine and esoteric diagnostics—we are poised to offer a more comprehensive experience to our customers. This will empower researchers and scientists with the essential tools to accelerate their growth and enhance efficiency in their workflows."

The collaboration between Dendi and MLP lays a crucial foundation for not only expediting lab deployment but also improving data interoperability and enhancing clinical diagnostics across various care settings. In an era where rapid testing and diagnostic capabilities are more vital than ever, this partnership represents a significant leap towards meeting those increasing demands.

About Dendi

Founded with the mission to deliver state-of-the-art software solutions for clinical laboratories across the United States, Dendi underscores its cloud-native capabilities, top-notch instrument interfacing, and robust API functionalities. The company prides itself on enabling laboratories to scale quickly and perform more effectively while improving diagnostic outcomes. Dendi is recognized for its exceptional customer support and agile software development processes, making it a valuable partner in the lab technology arena.

About Molecular Lab Partners (MLP)

Molecular Lab Partners focuses on streamlining the implementation of PCR testing for physician practices and high-complexity labs. They offer ready-to-use, custom-plated assays coupled with comprehensive support from licensing to validation, simplifying the process of launching and expanding molecular testing capabilities. The overarching goal of MLP is to ensure that lab setups are quick, efficient, and easy to navigate, allowing clients to refine their workflows and increase testing capacities with confidence.